Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768765 · ClinicalTrials.gov registry record
Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)
A clinical trial, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- 144
- Enrollment target
NCT03768765 is a clinical trial that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 144 participants.
The verdict
NCT03768765 was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- 144 participants
- Enrollment target
Study Summary
To determine if the prior prolonged use of medication, as a treatment for benign prostatic hyperplasia, reduces the efficacy of Holmium laser enucleation of the prostate (HoLEP) for patients with benign prostatic hyperplasia (BPH).
Interventions
- PROCEDURE Holmium Laser Prostate Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2018-11-15 |
| Est. Completion | 2024-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03768765
The ClinicalTrials.gov registry entry for NCT03768765 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Holmium Laser Prostate Surgery is the first listed.
NCT03768765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03768765 about?
NCT03768765 is a clinical study titled "Duration of Medication Therapy and Outcomes After Holmium Laser Prostate Surgery for Patients With Benign Prostatic Hyperplasia (BPH)". To determine if the prior prolonged use of medication, as a treatment for benign prostatic hyperplasia, reduces the efficacy of Holmium laser enucleation of the prostate (HoLEP) for patients with benign prostatic hyperplasia (BPH).
What is the current status of trial NCT03768765?
This trial is currently terminated. The enrollment target is 144 participants. The study started on 2018-11-15. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT03768765?
The interventions under investigation include: Holmium Laser Prostate Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT03768765?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.